Please provide your email address to receive an email when new articles are posted on . The extended depth of focus IOL has no warning on loss of contrast sensitivity. The lens will be available in ...
Major ophthalmic events in the first quarter of 2026 included treatments for presbyopia, age-related macular degeneration ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...
TECNIS PureSee IOL197% of patients would recommend this IOL to friends or family2TECNIS PureSee IOL is the first and only U.S. FDA-approved extended depth of focus (EDOF) IOL maintaining contrast ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The lens has extended depth of focus rather than a ...
FDA has approved Johnson & Johnson's Tecnis PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract surgery. The new IOL will be available to U.S. patients ...
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Johnson & Johnson (NYSE:JNJ) received FDA approval for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results